.jpg)
Venture Growth Equity Firm Raises New Fund to Continue Focus on Modernizing Healthcare
Questa Capital Management, a venture growth equity firm exclusively dedicated to the healthcare industry, today announced the final close of Questa Capital Partners III, LP (the "Fund") with $397 million of capital commitments, bringing the firm's aggregate committed capital to more than $1 billion. The Fund will invest selectively in a portfolio of growth companies in three healthcare sectors of focus: services, technology, and medical devices. The firm has an investment team of ten led by Founder Ryan Drant and Managing Partners Brad Sloan and Shawn Conway, and currently manages eighteen portfolio companies across its three healthcare sectors.
The Fund secured commitments from a diversified blue-chip investor base comprised of leading endowments, family offices, foundations, consultants, pension plans and fund-of-funds.
Questa Capital III will invest in growth companies in 3 healthcare sectors: services, technology and medical devices. Tweet this
Questa Founder and Managing Partner Ryan Drant noted, "We are extremely pleased to close on Fund III despite a challenging fundraising environment. We are both grateful for the strong interest and ongoing support from our existing investors, and pleased to be starting long-term relationships with a small group of exceptional new limited partners. We are honored to work closely with our portfolio companies, including marquee companies like Dispatch Health, Cortica, Medrio, and Calyxo. We are also energized by the opportunity set we see in the market, and look forward to continuing to build differentiated and high-growth healthcare companies in close collaboration with strong management teams. Questa will continue to partner with companies that share our vision and passion to improve clinical outcomes, efficiency, safety, and the patient experience to help address critical challenges in our healthcare system."
Questa Capital's record of being an active and collaborative partner for the companies in which it invests is a hallmark of the firm's approach. The Questa team brings deep sector expertise in healthcare services, technology, and medical devices, and a deep network and industry experience to help guide portfolio companies toward leading market positions and accelerated growth.
Value-based care is an important investment theme at Questa, and Fund I portfolio company Cortica is an excellent example of Questa's activity in the sector. "As Cortica continues to grow rapidly, Questa Capital has been an exceptional partner for our company as we build our team, broaden our relationships, and execute on our geographic expansion," said Neil Hattangadi MD, CEO and Co-Founder of Cortica. "Ryan and Brad are both extremely valued leaders on the Cortica board of directors. We congratulate them on their success in raising Fund III and look forward to our continued close collaboration."
Gunderson Dettmer served as legal counsel and Acalyx Advisors served as advisors to Questa Capital.
About Questa Capital Management
Questa Capital is a venture growth equity firm focusing on investments in expansion-stage healthcare companies. Questa seeks out disruptive, technology-enabled business models that help improve patient lives, streamline market inefficiencies, and provide better quality care. The firm partners with superior management teams to help build innovative market leaders in the healthcare services, technology, and medical devices sectors. Questa is led by industry veterans Ryan Drant, Brad Sloan and Shawn Conway, leaders in healthcare investment and operations who have invested in and advised more than 60 growth-stage companies.
More information is available at www.questacapital.com.
SOURCE Questa Capital
_____________________________________________________
FC Global Strategies enables medical, pharma, healthcare, medical device and healthcare IT companies to achieve their business and financial goals
Since 1979 FC Global Strategies has enabled companies globally to achieve their business and financial objectives.
If your company has business or financial objectives check out:
Strategic advisory services provided by FC Global Strategies
Medical and Pharma Insider’s AI Connect Marketing Program
Medical and Pharma Insider is a program of FC Global Strategies.
Click here to schedule a call to discuss your company's business and financial goals.
FC Global Strategies' Contacts:
North America and Latin America
Jeffrey Friedland (Based in the US)
+1 646 450 8909
jeffrey@fcglobalstrategies.com
The Middle East, North Africa and Eastern Europe
David Krutonog (Based in Israel)
+972 50 974 3429
david@fcglobalstrategies.com
Southeast Asia, Asia-Pacific, Australia, and New Zealand
Ross Swan (Based in Singapore)
+65 9181 9472
ross@fcglobalstrategies.com
Latin America
Claudio Hebling (Based in Brazil)
+55 19 99377 7482
claudio@fcglobalstrategies.com
South Asia
Vincent Paul Joseph (Based in India)
+91 962 620 9090
vincent@fcglobalstrategies.com
